16 / 24
Frequency of 2
nd
-Line Treatment Use in MPC
r = .495
P
= .0002
14
8
6
4
12
Frequency of 2
nd
-Line Chemotherapy (%)
60
30
70
40
50
20
Median Overall Survival (months)
10
Fitted values
Median OS
•
Frequency of 2
nd
-line chemotherapy use also higher in recent years
(vs pre-2007)
Nagrial AM, et al.
Crit Rev Oncol Hematol.
2015;96(3):483-497.
Trend in 2
nd
-Line Therapy Use in Metastatic
Pancreatic Cancer (MPC) in US: 2006-2015
Abrams TA, et al.
Oncologist,
2017;22(8):925-933.
2
nd-
Line Treatment